Literature DB >> 10481940

Differentially expressed genes associated with the metastatic phenotype in breast cancer.

D A Kirschmann1, E A Seftor, D R Nieva, E A Mariano, M J Hendrix.   

Abstract

We have previously shown that human breast carcinoma cells demonstrating an interconverted phenotype, where keratin (epithelial marker) and vimentin (mesenchymal marker) intermediate filaments are both expressed, have an increased ability to invade a basement membrane matrix in vitro. This increase in invasive potential has been demonstrated in MDA-MB-231 cells, which constitutively express keratins and vimentin, and in MCF-7 cells transfected with the mouse vimentin gene (MoVi). However, vimentin expression alone is not sufficient to confer the complete metastatic phenotype in MoVi cells, as determined by orthotopic administration. Thus, in the present study, differential display analysis was utilized to identify genes that are associated with the invasive and/or metastatic phenotype of several human breast cancer cell lines. Forty-four of 84 PCR fragments were differentially expressed as assessed by Northern hybridization analysis of RNA isolated from MCF-7, MoVi, and MB-231 cell lines. Polyadenylated RNA from a panel of poorly invasive, invasive/non-metastatic, and invasive/metastatic breast carcinoma cell lines was used to differentiate between cell-specific gene expression and genes associated with the invasive and/or metastatic phenotype(s). We observed that lysyl oxidase and a zinc finger transcription factor were expressed only in the invasive and/or metastatic cell lines; whereas, a thiol-specific antioxidant and a heterochromatin protein were down-regulated in these cells. In contrast, tissue factor was expressed only in breast carcinoma cell lines having the highest invasive potential. These results suggest that specific genes involved in breast cancer invasion and metastasis can be separated by differential display methodology to elucidate the molecular basis of tumor cell progression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481940     DOI: 10.1023/a:1006188129423

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  43 in total

1.  Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification.

Authors:  M Takahashi; D R Rhodes; K A Furge; H Kanayama ; S Kagawa; B B Haab; B T Teh
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

2.  Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition.

Authors:  Egle Avizienyte; Valerie J Fincham; Valerie G Brunton; Margaret C Frame
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

Review 3.  Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression.

Authors:  Pepper Schedin; Patricia J Keely
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

4.  Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells.

Authors:  Tissa T Manavalan; Yun Teng; Savitri N Appana; Susmita Datta; Theodore S Kalbfleisch; Yong Li; Carolyn M Klinge
Journal:  Cancer Lett       Date:  2011-09-10       Impact factor: 8.679

5.  Intracellular localization of the matrix enzyme lysyl oxidase in polarized epithelial cells.

Authors:  Matthias K Jansen; Katalin Csiszar
Journal:  Matrix Biol       Date:  2006-09-19       Impact factor: 11.583

Review 6.  Human copper-dependent amine oxidases.

Authors:  Joel Finney; Hee-Jung Moon; Trey Ronnebaum; Mason Lantz; Minae Mure
Journal:  Arch Biochem Biophys       Date:  2014-01-06       Impact factor: 4.013

7.  The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.

Authors:  Jason G Lieberthal; Marissa Kaminsky; Christopher N Parkhurst; Naoko Tanese
Journal:  Breast Cancer Res       Date:  2009-06-30       Impact factor: 6.466

8.  Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.

Authors:  Neill Patani; Wen Jiang; Robert Newbold; Kefah Mokbel
Journal:  J Carcinog       Date:  2010-11-12

9.  The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells.

Authors:  Alla Bondareva; Charlene M Downey; Fabio Ayres; Wei Liu; Steven K Boyd; Benedikt Hallgrimsson; Frank R Jirik
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

10.  Differential matrix rigidity response in breast cancer cell lines correlates with the tissue tropism.

Authors:  Ana Kostic; Christopher D Lynch; Michael P Sheetz
Journal:  PLoS One       Date:  2009-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.